Trial Profile
A Phase 2 study of Pirotinib
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 05 Sep 2018
Price :
$35
*
At a glance
- Drugs Pirotinib (Primary)
- Indications Non-small cell lung cancer; Solid tumours
- Focus Therapeutic Use
- 05 Sep 2018 New trial record